Cardio IQ LP-PLA2 Activity Biomarker Testing
It measures LP-PLA2 enzyme activity linked to vascular inflammation to refine heart risk; order through Vitals Vault with Quest collection and PocketMD support.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
LP-PLA2 activity is a blood test that looks at an enzyme involved in inflammation inside your artery walls. It is often used as a “risk-refiner” when you and your clinician are trying to understand your longer-term cardiovascular risk beyond standard cholesterol numbers.
This test does not tell you whether you have a blockage today. Instead, it helps estimate whether inflammatory processes associated with plaque development may be more active, which can matter even when your LDL cholesterol looks acceptable.
Your result is most useful when you interpret it alongside other risk inputs, such as LDL-C, apoB, lipoprotein(a), blood pressure, diabetes status, smoking history, and family history.
Do I need a Cardio IQ LP-PLA2 Activity test?
You may consider an LP-PLA2 activity test if your cardiovascular risk picture feels “in-between.” For example, your standard lipid panel might not look alarming, but you have a strong family history of early heart disease, features of metabolic syndrome, or you are trying to decide how aggressive to be with prevention.
This test can also be helpful if you have discordant markers, such as a normal LDL-C but elevated apoB or elevated lipoprotein(a) (Lp(a)). In those situations, LP-PLA2 activity can add another angle on whether inflammation related to atherosclerosis may be contributing to risk.
If you already have known coronary artery disease, diabetes, or multiple major risk factors, LP-PLA2 activity may be used as one more data point to track risk and response to lifestyle and medication changes. It is not a substitute for imaging, symptom evaluation, or clinician-directed care.
If you are using this test for self-education, treat it as a conversation starter: it can help you and your clinician decide what to check next and when to retest, rather than serving as a standalone diagnosis.
This is a CLIA laboratory blood test; results should be interpreted in clinical context and are not, by themselves, diagnostic of heart disease or a specific plaque burden.
Lab testing
Order Cardio IQ LP-PLA2 Activity through Vitals Vault
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
With Vitals Vault, you can order Cardio IQ LP-PLA2 Activity directly and complete your blood draw at a participating Quest collection site. That makes it easier to check a prevention-focused marker without waiting for a separate office visit.
After your results post, PocketMD can help you translate the number into plain language, identify the most relevant companion tests (such as apoB, hs-CRP, or Lp(a)), and draft questions to bring to your clinician. If you are tracking changes over time, you can also use the same ordering flow to retest on a consistent schedule.
If your result is high, the next step is usually not “panic,” but better context: confirming your overall lipid burden, checking for other inflammatory signals, and tightening the risk factors you can control (blood pressure, glucose, smoking, sleep, and exercise).
- Order online and draw at Quest collection locations
- PocketMD guidance for next steps and retest timing
- Designed for trend tracking alongside other heart-risk labs
Key benefits of Cardio IQ LP-PLA2 Activity testing
- Adds an inflammation-related signal that can refine cardiovascular risk beyond LDL cholesterol alone.
- Helps clarify risk when your lipid markers are discordant (for example, normal LDL-C but higher apoB).
- Supports more personalized prevention decisions when family history or metabolic risk factors are present.
- Provides a baseline you can trend after targeted lifestyle changes or clinician-directed lipid therapy.
- Pairs well with apoB, Lp(a), and hs-CRP to separate “lipid burden” from “inflammatory activity.”
- Can help prioritize follow-up testing (such as advanced lipids or imaging) when risk is uncertain.
- Gives you a concrete number to discuss with your clinician, with PocketMD help to interpret context.
What is Cardio IQ LP-PLA2 Activity?
LP-PLA2 stands for lipoprotein-associated phospholipase A2. It is an enzyme carried mainly on LDL particles in the bloodstream. The “activity” test measures how active this enzyme is, not just how much of it is present.
LP-PLA2 is linked to inflammatory processes in the artery wall. When LDL particles enter the vessel lining and undergo oxidative changes, inflammatory pathways can be triggered. LP-PLA2 participates in reactions that generate pro-inflammatory byproducts, which is why higher activity has been studied as a marker associated with atherosclerosis-related risk.
Because LP-PLA2 is connected to LDL particles, your result should be interpreted alongside measures of LDL particle burden (often apoB or LDL-P) and your overall risk profile. A single marker rarely tells the whole story, but LP-PLA2 activity can be useful when you are trying to understand whether inflammation may be adding risk on top of cholesterol exposure.
Activity vs. mass: why the wording matters
Some labs report LP-PLA2 “mass” (how much enzyme is present), while others report “activity” (how strongly it is functioning). These are related but not identical. If you are comparing results over time, try to use the same test type and the same lab method so your trend is meaningful.
How it fits into heart-risk assessment
LP-PLA2 activity is typically used as an adjunct marker. It does not replace a lipid panel, apoB, blood pressure assessment, diabetes screening, or clinician evaluation. It can be most helpful when you are deciding whether your risk is low enough to stay conservative or high enough to justify more aggressive prevention.
What do my Cardio IQ LP-PLA2 Activity results mean?
Low LP-PLA2 activity
A low result generally suggests less LP-PLA2-related inflammatory activity associated with LDL particles. In many people, this aligns with a lower inflammatory contribution to atherosclerosis risk, especially if other markers (apoB, LDL-C, hs-CRP) are also favorable. Low is not a guarantee of low risk, because plaque risk is also driven by lifetime cholesterol exposure, blood pressure, glucose, smoking, and genetics.
In-range / optimal LP-PLA2 activity
An in-range result usually means this particular inflammation-related signal is not elevated. Your next step is to interpret it with the rest of your cardiovascular profile, because “in range” can still coexist with high apoB, high Lp(a), or poorly controlled blood pressure. If you are monitoring prevention efforts, stable in-range results over time can be reassuring when other risk factors are also improving.
High LP-PLA2 activity
A high result suggests higher LP-PLA2 enzyme activity, which has been associated with increased vascular inflammation and higher atherosclerotic risk in some populations. It does not diagnose a blockage or predict an imminent event, but it can be a reason to tighten risk-factor control and to check companion markers that clarify the “why,” such as apoB (particle burden) and hs-CRP (systemic inflammation). Many clinicians also consider whether imaging (like coronary artery calcium scoring) is appropriate based on your age and overall risk.
Factors that influence LP-PLA2 activity
LP-PLA2 activity can track with LDL-related particle burden, so higher apoB or LDL-P may coincide with higher activity. Smoking, uncontrolled diabetes, and chronic inflammatory states can also shift cardiovascular risk biology and may influence how you interpret the result. Certain lipid-lowering therapies can change LDL particles and may affect LP-PLA2 activity over time, which is why trending matters. Lab methods and reference intervals vary, so interpret your number using the range on your report and avoid comparing across different assay types (activity vs mass).
What’s included
- Lp Pla2 Activity
Frequently Asked Questions
Do I need to fast for an LP-PLA2 activity test?
Fasting is often not required for LP-PLA2 activity itself. However, this test is commonly ordered alongside cholesterol or advanced lipid testing, which may have fasting preferences depending on your clinician and the lab. If you are pairing it with triglycerides or a full lipid workup, fasting can make results easier to compare over time.
What is a normal range for LP-PLA2 activity?
“Normal” depends on the lab method and the reference interval printed on your report. Many labs provide categories such as low, moderate, or high risk based on activity cutoffs. Use your report’s range for interpretation, and try to retest using the same method if you are tracking trends.
What is the difference between LP-PLA2 activity and LP-PLA2 mass?
LP-PLA2 mass measures how much enzyme is present, while LP-PLA2 activity measures how active the enzyme is. They can move together, but they are not interchangeable. If you are monitoring change over time, stick with the same type (activity vs mass) so you are comparing like with like.
How often should I retest LP-PLA2 activity?
Retesting is usually most useful after a meaningful change in your risk profile, such as starting or adjusting lipid-lowering therapy, stopping smoking, significant weight loss, or improved glucose control. A common interval is about 8–12 weeks after a major intervention, then less frequently once stable. Your clinician can tailor timing based on your baseline risk and what else is being monitored.
Can LP-PLA2 activity be high if my LDL cholesterol is normal?
Yes. LDL-C can look normal while LDL particle number (often reflected by apoB) is higher, and LP-PLA2 is carried on lipoproteins. Inflammation-related signals can also vary independently. That is why LP-PLA2 activity is often interpreted with apoB, Lp(a), hs-CRP, and your overall risk factors.
Does a high LP-PLA2 activity mean I have plaque in my arteries?
Not necessarily. A high result is a risk marker associated with vascular inflammation, but it does not directly measure plaque or blockage. If your overall risk is uncertain, your clinician may consider additional evaluation, which could include imaging or other cardiovascular testing, based on your age, symptoms, and risk profile.